Michael Gralinski

894 total citations
32 papers, 709 citations indexed

About

Michael Gralinski is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Gralinski has authored 32 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Gralinski's work include Cardiac electrophysiology and arrhythmias (13 papers), Cardiac Ischemia and Reperfusion (7 papers) and Ion channel regulation and function (5 papers). Michael Gralinski is often cited by papers focused on Cardiac electrophysiology and arrhythmias (13 papers), Cardiac Ischemia and Reperfusion (7 papers) and Ion channel regulation and function (5 papers). Michael Gralinski collaborates with scholars based in United States, Peru and Netherlands. Michael Gralinski's co-authors include Benedict R. Lucchesi, Kenneth S. Kilgore, Gregory S. Friedrichs, Simon Black, Edward M. Driscoll, Franz J. Hock, J G McCormack, Peter J. Manley, Michael A. Breider and Raymond J. Lipicky and has published in prestigious journals such as Circulation, Circulation Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michael Gralinski

32 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Gralinski United States 18 343 199 150 99 70 32 709
Gregory S. Friedrichs United States 18 463 1.3× 298 1.5× 184 1.2× 107 1.1× 114 1.6× 50 948
Fawzi Babiker Kuwait 17 369 1.1× 258 1.3× 192 1.3× 67 0.7× 34 0.5× 40 857
Erin A. Booth United States 15 144 0.4× 119 0.6× 152 1.0× 104 1.1× 76 1.1× 16 617
Natsuya Keira Japan 15 394 1.1× 288 1.4× 233 1.6× 157 1.6× 72 1.0× 66 917
Stanley R. Jolly United States 13 349 1.0× 137 0.7× 191 1.3× 167 1.7× 91 1.3× 31 716
Jun Asayama Japan 17 541 1.6× 265 1.3× 251 1.7× 137 1.4× 72 1.0× 66 1.0k
William G. Williams Canada 14 385 1.1× 246 1.2× 77 0.5× 222 2.2× 65 0.9× 29 994
Koen Raedschelders United States 14 131 0.4× 358 1.8× 212 1.4× 92 0.9× 51 0.7× 27 783
Gwo‐Jyh Chang Taiwan 20 449 1.3× 409 2.1× 109 0.7× 151 1.5× 78 1.1× 68 1.2k

Countries citing papers authored by Michael Gralinski

Since Specialization
Citations

This map shows the geographic impact of Michael Gralinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gralinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gralinski more than expected).

Fields of papers citing papers by Michael Gralinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gralinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gralinski. The network helps show where Michael Gralinski may publish in the future.

Co-authorship network of co-authors of Michael Gralinski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gralinski. A scholar is included among the top collaborators of Michael Gralinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gralinski. Michael Gralinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neves, Liomar A. A., et al.. (2023). Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension. Journal of Visualized Experiments. 2 indexed citations
2.
Rowe, Elizabeth S., et al.. (2021). A nephroprotective iodinated contrast agent with cardioprotective properties: A pilot study. Journal of Neuroimaging. 31(4). 706–713. 4 indexed citations
3.
4.
5.
Gralinski, Michael, et al.. (2014). Methods to Induce Experimental Hypertension. 1–164. 1 indexed citations
6.
Zopf, David A., et al.. (2011). C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats. European Journal of Pharmacology. 670(1). 195–203. 27 indexed citations
7.
Cushing, Daniel J., et al.. (2009). PM101: A cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. European Journal of Pharmacology. 607(1-3). 167–172. 23 indexed citations
8.
Cushing, Daniel J., et al.. (2009). Comparison of the Cardiac Electrophysiology and General Toxicology of Two Formulations of Intravenous Amiodarone in Dogs. Cardiovascular Toxicology. 9(3). 126–133. 10 indexed citations
9.
Cushing, Daniel J., et al.. (2009). The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period. Clinical and Experimental Pharmacology and Physiology. 37(3). 358–361. 22 indexed citations
10.
Khan, Kanwar Nasir M., et al.. (2001). Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxen. Veterinary Immunology and Immunopathology. 80(3-4). 309–314. 17 indexed citations
11.
Gralinski, Michael. (2000). The assessment of potential for QT interval prolongation with new pharmaceuticals. Journal of Pharmacological and Toxicological Methods. 43(2). 91–99. 22 indexed citations
12.
Gralinski, Michael, et al.. (1998). Effects of Troglitazone and Pioglitazone on Cytokine-Mediated Endothelial Cell Proliferation In Vitro. Journal of Cardiovascular Pharmacology. 31(6). 909–913. 39 indexed citations
13.
Tanhehco, Elaine J., et al.. (1997). Reviparin-Sodium Prevents Complement-Mediated Myocardial Injury in the Isolated Rabbit Heart. Journal of Cardiovascular Pharmacology. 30(5). 658–666. 5 indexed citations
14.
15.
Gralinski, Michael, et al.. (1996). Reduction of Myocardial Necrosis after Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours before Regional Ischemia and Reperfusion. Journal of Cardiovascular Pharmacology and Therapeutics. 1(3). 219–228. 17 indexed citations
16.
17.
Gralinski, Michael, Simon Black, Louis F. Stancato, et al.. (1996). Heat stress protects the perfused rabbit heart from complement-mediated injury. American Journal of Physiology-Heart and Circulatory Physiology. 271(2). H571–H578. 4 indexed citations
18.
Friedrichs, Gregory S., et al.. (1995). MS-551 Protects Against Ventricular Fibrillation in a Chronic Canine Model of Sudden Cardiac Death. Journal of Cardiovascular Pharmacology. 25(2). 314–323. 20 indexed citations
19.
Gralinski, Michael, et al.. (1994). Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Cardiovascular Research. 28(8). 1231–1237. 82 indexed citations
20.
Black, Shawn C., Michael Gralinski, James G. McCormack, Edward M. Driscoll, & Benedict R. Lucchesi. (1994). Effect of Ranolazine on Infarct Size in a Canine Model of Regional Myocardial Ischemia/Reperfusion. Journal of Cardiovascular Pharmacology. 24(6). 921–928. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory S. Friedrichs Breakdown of academic impact, for papers by Fawzi Babiker Breakdown of academic impact, for papers by Erin A. Booth Breakdown of academic impact, for papers by Natsuya Keira Breakdown of academic impact, for papers by Stanley R. Jolly Breakdown of academic impact, for papers by Jun Asayama Breakdown of academic impact, for papers by William G. Williams Breakdown of academic impact, for papers by Koen Raedschelders Breakdown of academic impact, for papers by Gwo‐Jyh Chang
Rankless by CCL
2026